AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Rigel Pharmaceuticals, Inc.

$51.31 +$9.48 (+22.66%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$51.45
Day Range
$50.67$52.60
Year Range
$24.95$52.61
Market Cap
958.46M
AVG Volume
289.47K
Trailing/Forward PE
2.9/11.2
PEG ratio
-0.06
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RIGL Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2276.79M
26 Q1299.77M
25 Q4294.28M
25 Q3282.08M
25 Q2267.92M
25 Q1203.08M
24 Q4179.28M
24 Q3157.47M
24 Q2130.3M
24 Q1120.35M
Net Income (USD) · TTM
-100M0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RIGL Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2321.91M
26 Q1364.23M
25 Q4367.02M
25 Q3113.3M
25 Q297.82M
25 Q137.18M
24 Q417.48M
24 Q33.88M
24 Q2-14.23M
24 Q1-19.8M
Operating Income (USD) · TTM
-50M050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
RIGL Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q287.05M
26 Q1124.58M
25 Q4125.47M
25 Q3118.95M
25 Q2104.59M
25 Q143.93M
24 Q424.19M
24 Q39.5M
24 Q2-9.02M
24 Q1-14.73M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: RIGL

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Rigel Pharmaceuticals, Inc.
RIGL
Stockpicker

Video analysis: RIGL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: RIGL

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.